Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000143

Chief Executive Officer sold 160,773 shares at an average $75.35 ($12,114,155)

  • Chief Executive Officer acquired 148,454 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Monia Brett P · Chief Executive Officer

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-09 Exercise or conversion : show line 1 in the form 10b5-1 +40,822 $60.89 $2,485,652 295,803 D
2026-03-09 Exercise or conversion : show line 2 in the form 10b5-1 +73,529 $60.89 $4,477,181 369,332 D
2026-03-09 Sale : show line 3 in the form 10b5-1 −7,382 $74.11 $547,087 361,950 D
2026-03-09 Sale : show line 4 in the form 10b5-1 −117,604 $75.26 $8,850,642 244,346 D
2026-03-09 Sale : show line 5 in the form 10b5-1 −1,684 $75.58 $127,282 242,662 D
2026-03-10 Exercise or conversion : show line 6 in the form 10b5-1 +34,103 $60.89 $2,076,532 276,765 D
2026-03-10 Sale : show line 7 in the form 10b5-1 −16,512 $75.47 $1,246,235 260,253 D
2026-03-10 Sale : show line 8 in the form 10b5-1 −17,591 $76.34 $1,342,909 242,662 D
Open-market sales · 160,773 sh · avg $75.35 · $12,114,155

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-03-09 Exercise or conversion : show line 9 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −40,822 107,632 D
2026-03-09 Exercise or conversion : show line 10 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −73,529 34,103 D
2026-03-10 Exercise or conversion : show line 11 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −34,103 0 D
Loading xslF345X05/edgardoc.xml…